Dexcom shares crash nearly 40% as execution miss drives 2024 guidance cut By

-- Dexcom slashed its guidance Thursday after reporting second-quarter revenue fell short of estimates as the diabetes management solutions provider flagged weaker execution of key strategies. 

Inc (NASDAQ:) fell more than 37% in premarket trading Friday.

The Formal foreign exchange platforms in 2019company now expects revenue of approximately $4.00B to $4.05B for the fiscal 2024, down from prior guidance of $4.20B to $4.35B. 

"While Dexcom advanced several key strategic initiatives in the second quarter, our execution did not meet our high standards," the company said.

The company Q2 earnings $0.43 per share on revenue of $1.00 billion, compared with estimates of $0.39 on revenue of $1.04B. 

For Q3, revenue was guided in a range of $ $975M to $1.00B, missing analyst estimates of $1.15B.  

"There’s no getting away from the fact that this Thursday’s update was a sharp turn in the wrong direction for Dexcom," JPMorgan analysts said in a note.

"We expect shares will struggle to outperform as it navigates these near-term challenges and works to rebuild investor trust," analysts added, downgrading the DXCM stock from Overweight to Neutral and nearly halving the price target from $145 to $75. 

"While we still walked away from earnings with some unanswered questions, we feel very confident that this is due to multiple self-inflicted issues rather than a market growth issue. The TAM is substantial and the opportunity remains for the long-term."

Meanwhile, comments from RBC analysts were notably less negative. While acknowledging that the execution miss was "disappointing," the investment bank believes the near 40% sell-off in the stock "is unjustified." 

"We are buyers on weakness," RBC added, maintaining an Outperform rating but trimming the target price from $165 to $145. 

Yasin Ebrahim contributed to this report.

Statement: The content of this article does not represent the views of FTI website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!